Pharmaceuticals
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the most recent publications within this specialty of the MedWorm directory. This is page number 18.
World Health Organization Grants Prequalification for Global Use to GSK’s 10-Valent Synflorix™ Vaccine
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Endorsement is first for vaccine for pneumococcal disease - a life-threatening disease affecting many children; follows first-ever World Pneumonia Day
Source: GSK news - November 6, 2009 Category: Pharmaceuticals Source Type: organizations
India, EU to resolve generic drugs exports tangleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The European Union (EU) is not opposed to exports of generic medicine by Indian companies through its ports, European Commissioner for Trade Catherine Ashton said here Friday.
Source: The Economic Times Healthcare and Biotech News - November 6, 2009 Category: Pharmaceuticals Source Type: news
Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The agenda for Arrowhead’s 2010 Personalized Medicine Partnerships Conference, which is set to take place on February 22-24, 2010 in Philadelphia, has been announced. At this three day conference we will highlight key issues in forming partnerships and engage the best speakers to share their experiences. (PRWeb Nov 6, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3163644.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
DIA Conference to Explore Components of Risk Management Plans As They Apply to Medicinal Products, Therapeutic Biologics and VaccinesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Expert speakers from industry, Health Canada, EMEA, FDA, and PMDA will lead presentations at the 2nd DIA Conference on Harmonization of Risk Management Plans to be held December 10-11, 2009 in Washington, DC. (PRWeb Nov 6, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3163264.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
GenericsWeb Celebrates 10 years of Excellence in Pharmaceutical Patent IntelligenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This month marks the 10 year anniversary of the founding of GenericsWeb as a supplier of premium patent information products and services to the Generic Pharmaceutical Industry. GenericsWeb now has customers in over 40 countries and offices in 3 continents, backed by its operating headquarters in Sydney, Australia. (PRWeb Nov 6, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3163854.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
FDA Commissioner Margaret Hamburg to Deliver Keynote Address at DIA 46th Annual Meeting, June 13-17, 2010 in Washington, DCEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Dr. Margaret Hamburg, Commissioner of the US Food and Drug Administration (FDA), will deliver the opening keynote address to more than 8,000 professionals from the biopharmaceutical and related sectors at the Drug Information Association (DIA) 46th Annual Meeting. (PRWeb Nov 5, 2009)
Read the full story at http://www.prweb.com/releases/dia-meeting/margaret-hamburg/prweb3156974.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
BioSoteria eLearning Executive Michelle Nolin Flewell Earns CertificationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drug safety specialty firm BioSoteria announced that its Vice President of eLearning and Informatics earned the Certified Professional in Learning and Performance™ (CPLP) credential from the American Society for Training and Development (ASTD) Certification Institute. Michelle Flewell has more than fifteen years of medical communications and health care training experience and is responsible for the development of the company's online pharmacovigilance curriculum eLadder™ Safety. (PRWeb Nov 5, 2009)
Read the full story at http://www.prweb.com/releases/pharmacoviglance/drugsafety/prweb3161774.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
Scott Miller's 'A Call To Arms' And 'Fatal Immunity' Are Available For World-Wide LicensingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Human Anthrax Vaccine Program must be stopped. Scott Miller and Company has completed the feature film "A Call to Arms:2009 Edition" and the one-hour television documentary "Fatal Immunity: The Human Anthrax Vaccine Story" to inform the public about the clear and present danger of top secret government science turned into for-profit human anthrax vaccines with no accountability to its victims. It is available for world-wide licensing by motion picture and television distributors and exhibitors. (PRWeb Nov 4, 2009)
Read the full story at http://www.prweb.com/releases/scottmillerandco/documentaryp...
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
Professor Steven Ley of University of Cambridge will Present Free Webinar, 'Application of the ReactIR Flow Cell to Continuous Processing Technology'Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This webinar, which will be presented on November 19 and is of interest to anyone working in continuous flow chemistry processing, will deal with the application of the ReactIR flow cell inline using various meso and micro scale flow chemistry equipment. Professor Ley's work of over 670 publications has been recognized with several prestigious prizes and awards, including most recently the 2009 Tetrahedron Prize. (PRWeb Nov 4, 2009)
Read the full story at http://www.prweb.com/releases/flow/cell/prweb3149774.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
Leading Oncologist Dr. Robert Shepard Joins Cornerstone Pharmaceuticals As Acting Chief Medical OfficerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Cornerstone Pharmaceuticals, Inc., a privately-held pharmaceutical company, announced that esteemed cancer drug developer and oncologist, Robert C. Shepard, M.D., F.A.C.P. has joined the company as its acting Chief Medical Officer (CMO). (PRWeb Nov 4, 2009)
Read the full story at http://www.prweb.com/releases/2009/11/prweb3161794.htm
Source: PRWeb: Medical Pharmaceuticals - November 6, 2009 Category: Pharmaceuticals Source Type: news
Amarin Appoints John F. Thero as Chief Financial OfficerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
DUBLIN--(HSMN NewsFeed)--Amarin Corporation plc (NASDAQ:AMRN ) today announced the appointment of John F. Thero as the Companys Chief Financial Officer. In this role, Mr. Thero will have broad responsibility for financial and administrative matters of the... Biopharmaceuticals, PersonnelAmarin Corp, hypertriglyceridemia
Source: HSMN NewsFeed - November 6, 2009 Category: Pharmaceuticals Source Type: news
Stellar Pharmaceuticals Inc.: Stellar Pharmaceuticals' Q3-2009 Financial Results Marked by Strong Growth and Continued ProfitabilityEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
LONDON, ONTARIO (MARKET WIRE) Stellar Pharmaceuticals Inc. ("Stellar" or "the Company") (OTCBB: SLXCF), a Canadian pharmaceutical developer and marketer of high quality, cost-effective products for select health care markets, today announced its financial results for the third quarter ended September 30, 2009. In this press release, unless otherwise indicated, all dollar amounts are expressed in Canadian dollars and have been rounded to nearest hundred.
Source: Market Wire - Pharmaceuticals and Biotech - November 6, 2009 Category: Pharmaceuticals Tags: Pharmaceuticals and Biotech Medical and Healthcare SLXCF Source Type: news
Theravance and Astellas Announce the Commercial Launch of Vibativ (telavancin) in the United StatesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SOUTH SAN FRANCISCO, CA and DEERFIELD, IL – November 5,
2009 – Theravance, Inc. (NASDAQ:
THRX) and Astellas Pharma US, Inc.
announced today the commercial launch of VIBATIV
™ (telavancin) in the United States. On
September 11,...
Source: Drugs.com - Pharma News - November 6, 2009 Category: Pharmaceuticals Source Type: news
DOJ Investigates Alleged Fraud By Drugmakers; Sanctions On WellCare LiftedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
News outlets focus on alleged fraud in the drug and insurance industries. "A $112 million settlement involving alleged drug kickbacks that the Justice Dept. announced with the nation's largest nursing home pharmacy and a generic drug manufacturer on Nov. 3 is part of a wide-ranging investigation of suspected Medicaid fraud by the pharmaceutical industry,"
Source: Pharma Industry News From Medical News Today - November 6, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II Interim Data at Annual Meeting of the Connective Tissue Oncology SocietyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
-- Palifosfamide prolongs progression-free survival by at
least 50% --
NEW YORK--(BUSINESS WIRE)--Nov 6, 2009 - ZIOPHARM Oncology, Inc.
(Nasdaq: ZIOP) presented today at the 15th Annual
Connective Tissue Oncology Society (CTOS) Meeting, positive...
Source: Drugs.com - Clinical Trials - November 6, 2009 Category: Pharmaceuticals Source Type: clinical trials
Wall Street Journal Examines Big Pharma's 'Growing Interest' In Emerging-Market Vaccine Development, ProductionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Wall Street Journal examines "big pharma's growing interest in a corner of healthcare - emerging-market inoculations," in light of a recent move by Novartis to purchase an 85 percent stake in the Chinese vaccine maker Zhejiang Tianyuan Bio-Pharmaceutical Co.
Source: Pharma Industry News From Medical News Today - November 6, 2009 Category: Pharmaceuticals Tags: Pharma Industry / Biotech Industry Source Type: news
EpiCept Corporation Names Bernard Tyrrell as Senior Vice President, Sales and MarketingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
TARRYTOWN, N.Y., Nov. 6--(HSMN NewsFeed)--EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that it has appointed Bernard R. Tyrrell as the Companys Senior Vice President, Sales and Marketing, a newly created position. Mr. Tyrrell... Biopharmaceuticals, PersonnelEpiCept
Source: HSMN NewsFeed - November 6, 2009 Category: Pharmaceuticals Source Type: news
Helix BioPharma Corp. Completes Enrollment In Its Phase II Trial Of Topical Interferon Alpha-2b In Patients With Ano-Genital WartsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Helix BioPharma Corp. (TSX, FSE: "HBP" / OTCQX: HXBPF) announced that its Phase II trial of Topical Interferon Alpha-2b for the treatment of ano-genital warts (AGW) has completed patient enrollment, with the required 120th patient randomized to enter the trial. The double-blind and placebo-controlled Phase II trial is underway at multiple centers in Germany and Sweden.
Source: Pharma Industry News From Medical News Today - November 6, 2009 Category: Pharmaceuticals Tags: Cervical Cancer / HPV Vaccine Source Type: news
Amgen Announces Overall Survival Results For Vectibix(R) In First-Line Metastatic Colorectal CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Amgen (Nasdaq: AMGN) announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
Source: Pharma Industry News From Medical News Today - November 6, 2009 Category: Pharmaceuticals Tags: Colorectal Cancer Source Type: news
McNeil Consumer Healthcare Announces Voluntary Recall Of Certain Lots Of TYLENOL Arthritis Pain 100 Count With EZ-OPEN CAPEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In consultation with the U.S. Food and Drug Administration (FDA), McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc., is initiating a voluntary recall of a limited number of product lots of TYLENOL Arthritis Pain Caplet 100 count bottles, with the distinctive red EZ-OPEN CAP.
Source: Pharmaceutical Online News - November 6, 2009 Category: Pharmaceuticals Source Type: news
1930s Drug Slows Tumor GrowthEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. The newest surprise discovered by researchers at the Johns Hopkins University School of Medicine is a gonorrhea medication that might help battle cancer.
Source: Pharmaceutical Online News - November 6, 2009 Category: Pharmaceuticals Source Type: news
Catalent Qualifies Test for Melamine in Raw MaterialsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Catalent has successfully qualified a method for determining if suspect excipients are contamination-free.
Source: PharmaManufacturing.com - November 6, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
AstraZeneca Joins the List of Corporate BloggersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Source: PharmaManufacturing.com - November 6, 2009 Category: Pharmaceuticals Authors: Pharma Manufacturing Source Type: info
Coloplast Full Year Report 2008/09: EBIT-Margin Up 4%-PointsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
HUMLEBAEK, Denmark, Nov. 6, 2009 (GLOBE NEWSWIRE) -- Coloplast's full year announcement reveals a vast increase in profitability. In 2008/09, the company realised EBIT of DKK 1,395m equal to an EBIT margin of 16% against 12% last year. In Q4, 2008/09 profit was DKK 406m equal to an EBIT margin of 18%.
Source: Medical News (via PRIMEZONE) - November 6, 2009 Category: Pharmaceuticals Source Type: news
IMS Health in $5.2bn leveraged buy-outEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The prescription-drug data provider has agreed to sell itself to TPG Capital and Canada Pension Plan's investment board in what is the biggest such deal this year
Source: FT.com - Drugs and Healthcare - November 6, 2009 Category: Pharmaceuticals Source Type: news
Drug group acquisition boosts BTGEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A full half-year of contributions from Protherics boost revenues at the biotechnology group as it looks forward to the direct marketing of two major drugs in the US next year
Source: FT.com - Drugs and Healthcare - November 6, 2009 Category: Pharmaceuticals Source Type: news
ISPE Releases Its Oral Solid Dosage Forms Baseline Guide, Second EditionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
ISPE, a global not-for-profit association of 24,000 technical professionals working in the manufacturing and drug development sectors of the pharmaceutical industry, recently announced the release of its Oral Solid Dosage (OSD) Forms Baseline® Guide, Second Edition - the latest ISPE publication reviewed by the US FDA.
Source: Pharmaceutical Online News - November 6, 2009 Category: Pharmaceuticals Source Type: news
CSI Introduces New Solution For Tote UnloadingEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CSI introduces an innovative new solution
for processors who use Intermediate Bulk Containers (IBC).
Source: Pharmaceutical Online News - November 6, 2009 Category: Pharmaceuticals Source Type: news
Democrats Pose Health Bill HurdleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As Democratic leaders ramp up efforts to pass health legislation, they must satisfy the individual priorities of all the Democrats in the Senate and two Democratic-friendly independents.
Source: WSJ.com: Health - November 6, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
AARP, AMA Endorse Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
House Democrats' health bill got a boost with endorsements by AARP and the AMA, which Obama seized on to push for support with hours ticking down before a scheduled Saturday vote.
Source: WSJ.com: Health - November 6, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Cigna Says Net Rose 92%Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The New York State Insurance Department is looking into allegations that Cigna failed to accurately account for $5 billion in health-care premiums in its disclosures to regulators.
Source: WSJ.com: Health - November 6, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
Democrats Are Own Hurdle on Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As Democratic leaders ramp up efforts to pass health legislation, they must satisfy the individual priorities of the 60 Democrats in the Senate and two Democratic-friendly independents.
Source: WSJ.com: Health - November 6, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Uproar as Firms Get Swine-Flu VaccineEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The CDC director urged health officials around to ensure swine-flu vaccine is getting to high-risk groups, after criticism erupted over distribution to some Wall Street firms.
Source: WSJ.com: Health - November 6, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
AARP, AMA Endorse Health BillEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
House Democrats' health bill got a boost with endorsements by AARP and the AMA, which Obama seized on to push for support with hours ticking down before a scheduled Saturday vote.
Source: WSJ.com: Health - November 6, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal CancerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Amgen (Nasdaq: AMGN) today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
Source: World Pharma News - November 6, 2009 Category: Pharmaceuticals Source Type: news
Novartis to expand its human vaccines presence in ChinaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Novartis has reached an agreement to acquire an 85% stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical Co., Ltd. as part of a strategic initiative to build a vaccines industry leader in this country and expand the Group's limited presence in this fast-growing market segment.
Source: World Pharma News - November 6, 2009 Category: Pharmaceuticals Source Type: news
Obama Trumpets Support From AMAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The nation's largest doctors' group said it supports the health-care bill due for a House vote this week, but insisted it must be paired with a Medicare fix.
Source: WSJ.com: Health - November 5, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Cigna Premium Disclosures ProbedEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The New York State Insurance Department is looking into allegations that Cigna failed to accurately account for $5 billion in health-care premiums in its disclosures to regulators.
Source: WSJ.com: Health - November 5, 2009 Category: Pharmaceuticals Tags: PAID Source Type: news
AMA Uneasy In Support Of ObamaCareEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The doctors group is pushing for reform to include a hike in Medicare reimbursements, but Congress may not play along.
Source: Forbes.com Healthcare News - November 5, 2009 Category: Pharmaceuticals Source Type: news
HealthTronics, Inc. Announces Third Quarter Results, Positive Contribution From Endocare; Richard Rusk Appointed Chief Financial OfficerEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AUSTIN, Texas, Nov. 5, 2009 (GLOBE NEWSWIRE) -- HealthTronics, Inc. (Nasdaq:HTRN), a leading provider of Urology services and products, today announced its financial results for the quarter ended September 30, 2009.
Source: Medical News (via PRIMEZONE) - November 5, 2009 Category: Pharmaceuticals Source Type: news
Alphatec Spine, Inc. Enters Supply and Distribution Agreement With ETEX Corporation for Novel Biologics ProductsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
CARLSBAD, Calif., Nov. 5, 2009 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (Nasdaq:ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that it has entered into a supply and distribution agreement with ETEX Corporation, pursuant to which ETEX will provide Alphatec Spine non-exclusive rights to market and sell ETEX's EquivaBone and CarriGen(R) products in the United States and Europe, excluding Spain.
Source: Medical News (via PRIMEZONE) - November 5, 2009 Category: Pharmaceuticals Source Type: news
NightHawk Radiology Holdings, Inc. Announces Third Quarter 2009 ResultsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SCOTTSDALE, Ariz., Nov. 5, 2009 (GLOBE NEWSWIRE) -- NightHawk Radiology Holdings, Inc. (Nasdaq:NHWK), the leading provider of radiology solutions to radiology groups across the United States, today announced its financial results for third quarter 2009.
Source: Medical News (via PRIMEZONE) - November 5, 2009 Category: Pharmaceuticals Source Type: news
Obama Trumpets Support From AMAEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The nation's largest doctors' group said it is supports health-care bill due for a vote in the House this week, but insisted that it must be paired with a Medicare fix.
Source: WSJ.com: Health - November 5, 2009 Category: Pharmaceuticals Tags: FREE Source Type: news
Alphatec Spine, Inc. Enters Supply and Distribution Agreement With ETEX Corporation for Novel Biologics ProductsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Agreement Allows Immediate Access to EquivaBone(R), a Unique Osteoinductive and Osteoconductive Material With Superior Handling Qualities
CARLSBAD, Calif., Nov. 5, 2009 --(HSMN NewsFeed) -- Alphatec Holdings, Inc. (Nasdaq:ATEC ), the parent company of A... Devices, Distribution, Neurosurgery, OrthopaedicAlphatec Holdings, ETEX Corp, EquivaBone, CarriGen, demineralized bone matrix
Source: HSMN NewsFeed - November 5, 2009 Category: Pharmaceuticals Source Type: news
Theravance and Astellas Announce the Commercial Launch of VIBATIV(TM) (telavancin) in the United StatesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
SOUTH SAN FRANCISCO, CA and DEERFIELD, IL, Nov. 5 -- (HSMN NewsFeed) - Theravance, Inc. (NASDAQ:THRX ) and Astellas Pharma US, Inc. announced today the commercial launch of VIBATIV(TM) (telavancin) in the United States. On September 11, 2009, the U.S. Food... BiopharmaceuticalsTheravance, Astellas Pharma, VIBATIV, telavancin, cSSSI
Source: HSMN NewsFeed - November 5, 2009 Category: Pharmaceuticals Source Type: news
Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of DirectorsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
BOTHELL, Wash., Nov. 5 (HSMN NewsFeed) -- Cardiac Science Corporation (Nasdaq: CSCX ), a global leader in automated external defibrillator (AED) and diagnostic cardiac monitoring devices, announced today it appointed veteran healthcare executive Ronald A... Devices, Cardiology, Monitoring, PersonnelCardiac Science, automated external defibrillator
Source: HSMN NewsFeed - November 5, 2009 Category: Pharmaceuticals Source Type: news
